IRadimed announced Wednesday, Dec. 19, that the company has gained FDA clearance for its 3883 MRI-compatible blood pressure module.
The solution was designed to be used alongside its 3880 MRI-compatible vital signs monitor, a lightweight system that provides uninterrupted monitoring during patient transport.
“Customers can now provide a more comprehensive suite of vital signs monitoring while transporting patients from hospital critical care departments to the MRI scanner room and back to critical care while maintaining continuous vital signs monitoring,” Roger Susi, president and CEO of IRadimed said in a prepared statement.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.